Nanoform Finland (FRA:4YL) FCF Yield % : -12.07 (As of May. 07, 2024)

View and export this data going back to 2020. Start your Free Trial

What is Nanoform Finland FCF Yield %?

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, Nanoform Finland's Trailing 12-Month Free Cash Flow is €-21.81 Mil, and Market Cap is €180.72 Mil. Therefore, Nanoform Finland's FCF Yield % for today is -12.07%.

The historical rank and industry rank for Nanoform Finland's FCF Yield % or its related term are showing as below:

FRA:4YL' s FCF Yield % Range Over the Past 10 Years
Min: -22.52 Med: -8.45 Max: -3.2
Current: -12.07

During the past 8 years, the highest FCF Yield % of Nanoform Finland was -3.20%. The lowest was -22.52%. And the median was -8.45%.

FRA:4YL's FCF Yield % is ranked better than
53.7% of 1555 companies
in the Biotechnology industry
Industry Median: -14.23 vs FRA:4YL: -12.07

Nanoform Finland's FCF Margin % for the quarter that ended in Dec. 2023 was -1,305.00%.

Nanoform Finland FCF Yield % Historical Data

The historical data trend for Nanoform Finland's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nanoform Finland FCF Yield % Chart

Nanoform Finland Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

FCF Yield %

Get a 7-Day Free Trial

-3.61

-4.72

-12.00

-17.54

Nanoform Finland Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
FCF Yield %	Get a 7-Day Free Trial															-11.60	-16.93	-14.74	-16.59	-16.80

Competitive Comparison of Nanoform Finland's FCF Yield %

For the Biotechnology subindustry, Nanoform Finland's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Nanoform Finland's FCF Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Nanoform Finland's FCF Yield % distribution charts can be found below:

* The bar in red indicates where Nanoform Finland's FCF Yield % falls into.

Nanoform Finland FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

Nanoform Finland's FCF Yield % for the fiscal year that ended in Dec. 2023 is calculated as

FCF Yield %	=	Free Cash Flow	/	Market Cap
	=	-21.808	/	124.31789
	=	-17.54%

Nanoform Finland's annualized FCF Yield % for the quarter that ended in Dec. 2023 is calculated as

FCF Yield %	=	Free Cash Flow	*	Annualized Factor	/	Market Cap
	=	-5.22	*	4	/	124.31789
	=	-16.80%

Nanoform Finland FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.

Nanoform Finland FCF Yield % Related Terms

Thank you for viewing the detailed overview of Nanoform Finland's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.

Nanoform Finland (FRA:4YL) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Nanoform Finland PLC (FRA:4YL) » Definitions » FCF Yield %

Comparable Companies

Traded in Other Exchanges

NANOFS:Sweden NANOFH:Finland 4YL:Germany

Address

Cultivator II, Viikinkaari 4, Helsinki, FIN, 00790

Website

https://www.nanoform.com

Nanoform Finland PLC is a nanoparticle medicine-enabling company. The company works together with pharma and biotech partners to reduce attrition in clinical trials and enhance their molecules' formulation performance through its nano-forming services. Its patented and scalable Controlled Expansion of Supercritical Solutions (CESS) technology produces nano-formed API particles as small as 10nm. This enables poorly soluble molecules in the pharmaceutical pipeline to progress into clinical development by increasing their rate of dissolution and by improving their bioavailability. Its technology provides novel opportunities in many value-enhancing drug delivery applications.

Nanoform Finland (FRA:4YL) Headlines

No Headlines